CLINICAL ROLE -
Metformin Observed to Reduce Heart Disease Risk in Type 1 Diabetes
REMOVAL trial results presented at the American Diabetes Association’s 77th Scientific Sessions.
Read More
Personalized Dosing in Firstline Advanced Lung Cancer Would Save US Millions
The FDA recommends a 200-mg dose of pembrolizumab every 3 weeks, but researchers disagree.
State Biosimilar Bill Signed into Law
Another state passes legislation to increase uptake of biosimilars.
Physician Satisfaction May Influence Oncology Prescribing
Taking steps to improve customer satisfaction may increase oncology revenue for manufacturers.
Guardians of the Galaxy Star Calls Attention to HIV Awareness in Sia Music Video
HIV/AIDS is the number 1 killer among women of reproductive age.
Healthy Obesity Still Leads to Cardiovascular Events
Patients with metabolically healthy obesity have a 50% increased risk of coronary heart disease.
HDAC Inhibitors May Have Potential to Treat Psoriasis
Agents fight cancer by temporarily loosening DNA, increasing the expression of tumor suppressors, and making the tumor more vulnerable.
FDA Approves Oral Powder for Pediatric HIV Treatment
Powder formulation of HIV drug receives FDA approval.
Pharmacy Week in Review: June 9, 2017
A look at the top stories in pharmacy last week.
Watch
Oral Pediatric HIV Treatment Gets FDA Approval
Ritonavir is indicated in combination with other antiretroviral agents for the treatment of pediatric patients with HIV-1.
Illicit Drug Use Significantly Underreported
Survey methods may lead to varying responses to questions related to drug use.
Oral Add-On Drug to Methotrexate Shows Promise in Rheumatoid Arthritis
Filgotinib may offer new option for patients with rheumatoid arthritis who have an inadequate response to methotrexate.
PCSK9 Inhibitors Reduce Cardiovascular Risks in Type 2 Diabetes
Results of the ODYSSEY study presented at the American Diabetes Association’s 77th Scientific Sessions.
Trending News Today: AHCA Could Make Maintaining Healthcare While Switching Jobs More Difficult
Top news of the day from across the healthcare landscape.
Findings from inTandem1 and inTandem2 Featured at ADA Scientific Sessions
Sotagliflozin effective in treating patients with type 1 diabetes.
Soliqua Shows Promise Lowering Hemoglobin A1C Levels in Type 2 Diabetes
Findings presented at ADA conference highlight effiacy of insulin glargine/lixisenatide combination.
Trending News Today: Knowledge Gap Found in Patients With Advanced Cancer
Top news of the day from across the health care landscape.
The Pharmacist's Role in Evaluating Complementary, Alternative Medicine
Use of natural, herbal, vitamin, and traditional cures available in grocery stores, gas stations, drugstores, health food stores, and from the Internet continues to grow.
Study Shows Switching to Toujeo Lowers Risk of Hypoglycemia in Seniors With Diabetes
Patients who switched to insulin glargine were 57% less likely to experience hypoglycemia.
Texting System Helps Teens With Diabetes Improve Glycemic Control
Two-way text messaging system either maintained or improved A1C levels for teens with type 1 diabetes.
Medicare Drug Rebate Debate Highlights AJPB Week in Review
Top articles of the week from The American Journal of Pharmacy Benefits.
Eicosapentaenoic Acid May be Beneficial for Diabetes Patients
Icosapeny ethyl reduced triglyceride levels for patients with diabetes, according to a session presented at the ADA 77th Annual Scientific Sessions.
Risk of Type 2 Diabetes Skyrockets in Severely Obese Children
Severe obesity in childhood leads to 12 times greater risk of developing type 2 diabetes (T2D) by age 20, according to study presented at ADA’s 77th Scientific Session.
Overweight Male Children Can Still Avoid Type 2 Diabetes in Adulthood
Study presented at ADA’s 77th Scientific Sessions finds boys who are overweight during childhood can normalize their weight as young adults without an elevated diabetes risk.
Inhibiting PCSK9 in Dyslipidemia Patients with Diabetes
Symposium on PCSK9 inhibitors in treatment of type 1 diabetes highlighted at 77th Scientific Sessions of the ADA.
DEVOTE Trial Shows Cardiovascular Safety Data for Insulin Degludec
Tresiba found to offer patients with type 2 diabetes (T2D) a lower risk of severe hypoglycemia.
HIV Diagnoses in New Zealand Hit Record High
Men who have sex with men had the highest number of HIV diagnoses.
Study: Safe Spaces for Drug Use Could Save Millions Annually
Facilities for safe drug use may prevent deaths, hospitalizations, and infections related to injection drug use, according to a new study.
FDA Approves Generic Truvada
The drug is indicated as a combination treatment of HIV and for pre-exposure prophylaxis.
Generic HIV Drug Gets FDA Approval
FDA approves first generic version of emtricitabine and tenofovir disoproxil fumarate (Truvada).
